Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KLK7 | P49862 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.47 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9734555 | 0.85 | ESR1 (0.53) | HTTSMN1; SMN2LMNA | |
| SCHEMBL28657956 | 0.85 | LDHA (0.59) | HTTALDH1A1KLK7KDM4EPOLB | |
| SCHEMBL9780185 | 0.83 | HTT (0.38) | HTTALDH1A1KLK7POLB | |
| SCHEMBL3829820 | 0.82 | HTT (0.59) | HTTALDH1A1KLK7KDM4EPOLB | |
| SCHEMBL9780186 | 0.81 | SLC6A4 (0.46) | ALDH1A1KDM4ELMNA | |
| SCHEMBL27985109 | 0.80 | ALDH1A1 (0.55) | HTTALDH1A1POLBSMN1; SMN2LDHA | |
| SCHEMBL28500649 | 0.79 | HTT (0.56) | HTTALDH1A1KLK7KDM4EPOLB | |
| SCHEMBL8951701 | 0.79 | HTT (0.56) | HTTALDH1A1KLK7SMN1; SMN2LDHA | |
| SCHEMBL27746899 | 0.79 | HTT (0.59) | HTTALDH1A1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL11082660 | 0.77 | HTT (0.58) | HTTALDH1A1KDM4EPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5135940-A | Antiallegens, antiinflammatory agents | MERCK FROSST CANADA, INC. (CA) | 1992-08-04 | — | — | US | disclosed |
| EP-0252639-A1 | Leukotriene antagonists | MERCK FROSST CANADA INC. (CA) | 1988-01-13 | — | — | EP | disclosed |
| EP-0104885-B1 | LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM | MERCK FROSST CANADA INC. (CA) | 1986-06-04 | — | — | EP | disclosed |
| EP-0156233-A2 | Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions | MERCK & CO. INC. (US) | 1985-10-02 | — | — | EP | disclosed |
| EP-0104885-A1 | Leukotriene antagonists, their production, and compositions containing them | MERCK FROSST CANADA INC. (CA) | 1984-04-04 | — | — | EP | disclosed |